XML 100 R5.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Consolidated Balance Sheets - USD ($)
Dec. 31, 2019
Jun. 30, 2019
Current assets:    
Cash and cash equivalents $ 1,500,400,000 $ 1,949,200,000
Short-term marketable securities 7,200,000 10,500,000
Accounts receivable, net of allowance for doubtful accounts of $53.1 and $54.9, respectively 2,587,900,000 2,439,300,000
Other current assets 660,900,000 509,100,000
Total current assets before funds held for clients 4,756,400,000 4,908,100,000
Funds held for clients 36,608,600,000 29,434,200,000
Total current assets 41,365,000,000.0 34,342,300,000
Long-term receivables, net of allowance for doubtful accounts of $0.5 and $0.4, respectively 21,600,000 23,800,000
Property, plant and equipment, net 761,300,000 764,200,000
Operating lease right-of-use asset 500,200,000 0
Deferred contract costs 2,397,300,000 2,428,500,000
Other assets 596,600,000 934,400,000
Goodwill 2,314,900,000 2,323,000,000.0
Intangible assets, net 1,102,500,000 1,071,500,000
Total assets 49,059,400,000 41,887,700,000
Current liabilities:    
Accounts payable 132,900,000 125,500,000
Accrued expenses and other current liabilities 2,051,500,000 1,759,000,000.0
Accrued payroll and payroll-related expenses 428,700,000 721,100,000
Dividends payable 389,300,000 340,100,000
Short-term deferred revenues 210,400,000 220,700,000
Obligations under reverse repurchase agreements (A) [1] 0 262,000,000.0
Short-term debt 1,001,600,000 0
Income taxes payable 38,100,000 54,800,000
Total current liabilities before client funds obligations 4,252,500,000 3,483,200,000
Client funds obligations 36,269,900,000 29,144,500,000
Total current liabilities 40,522,400,000 32,627,700,000
Long-term debt 1,003,000,000.0 2,002,200,000
Operating lease liabilities 360,200,000 0
Other liabilities 726,000,000.0 798,700,000
Deferred income taxes 702,400,000 659,900,000
Long-term deferred revenues 381,000,000.0 399,300,000
Total liabilities 43,695,000,000.0 36,487,800,000
Commitments and contingencies (Note 13)
Stockholders' equity:    
Preferred stock, $1.00 par value: authorized, 0.3 shares; issued, none 0 0
Common stock, $0.10 par value: authorized, 1,000.0 shares; issued, 638.7 shares at December 31, 2019 and June 30, 2019; outstanding, 431.8 and 434.2 shares at December 31, 2019 and June 30, 2019, respectively 63,900,000 63,900,000
Capital in excess of par value 1,253,700,000 1,183,200,000
Retained earnings 17,987,600,000 17,500,600,000
Treasury stock - at cost: 206.9 and 204.5 shares at December 31, 2019 and June 30, 2019, respectively (13,709,600,000) (13,090,500,000)
Accumulated other comprehensive loss (231,200,000) (257,300,000)
Total stockholders’ equity 5,364,400,000 5,399,900,000
Total liabilities and stockholders’ equity $ 49,059,400,000 41,887,700,000
Long-term Marketable Securities Under Reverse Repurchase Agreements   261,400,000
Cash And Cash Equivalents Under Reverse Repurchase Agreements   $ 600,000
[1] (A) As of June 30, 2019, $261.4 million of long-term marketable securities and $0.6 million of cash and cash equivalents have been pledged as collateral under the Company's reverse repurchase agreements. Refer to Note 9